Navigation Links
McKesson Expands Pharmacy Automation Product Portfolio to Include I.V. Therapy
Date:8/10/2009

BOZEN, Italy, August 10 /PRNewswire/ --

- Strategic Partnership Announced With Health Robotics

Health Robotics today announced that it has signed an exclusive five-year strategic partnership with McKesson for Health Robotics' CytoCare Robot. The agreement enables McKesson to achieve its goal of safely, accurately and cost-effectively automating the preparation of Oncology I.V. admixtures.

"We are very pleased to have been chosen by Health Robotics as their exclusive CytoCare partner in our core markets of the United States and Canada", stated David Souerwine, President, McKesson Automation. "CytoCare, a-one-of-its-kind solution, represents an ideal complement to ROBOT-Rx(R) and MedCarousel(R) technologies, and our entire suite of Automation solutions."

McKesson believes that CytoCare has the potential to become the gold standard for Oncology I.V. admixtures in North America, equally protecting clinicians and patients. The successful installations of the CytoCare Robot in the United States, including the University of Colorado Hospital in Denver, show synergies between CytoCare and both McKesson Automation and other McKesson Provider Technologies market-leading solutions.

"McKesson is the ideal partner for Health Robotics in North America due to its commitment to medication safety, company stability, market footprint, world-class service infrastructure, and complementary oral medication automation technologies. I was extremely impressed to see their manufacturing and customer services operations in Pittsburgh; they are exactly what CytoCare customers need in North America: a knowledgeable, committed, resourceful, and customer-focused organization. This is precisely what Health Robotics requires at this moment in time to take CytoCare to the next level of market acceptance and customer-service focus in North America. I'm sure this is just the beginning of a long-term partnership expanding into manufacturing and other fields of I.V. Robotics Automation", stated Werner Rainer, Chairman and CEO of Health Robotics.

About Health Robotics:

Health Robotics is the global leading supplier of life-critical intra-venous medication preparation, compounding, and dispensing Robots, providing healthcare facilities in four continents with robotics technology and software automation solutions. The world-leading solutions CytoCare [hazardous IVs], i.v.STATION [non-hazardous IVs], i.v.SOFT [workflow engine] and the future development of TPNstation, have and will greatly contribute to ease global hospitals' growing pressures to improve patient safety through the effective and efficient production of sterile, accurate, and ready-to-administer IVs, to eliminate life-threatening drug-exchange errors, to decrease other medication errors and sterility risks, and to work more efficiently, increase throughput, reduce waste, and contain costs. For more information, visit http://www.health-robotics.com

About McKesson:

McKesson Corporation, currently ranked 15th on the FORTUNE 500, is a healthcare services and information technology company dedicated to helping its customers deliver high-quality healthcare by reducing costs, streamlining processes, and improving the quality and safety of patient care. McKesson has been in continuous operation for more than 175 years, making it the longest-operating company in healthcare today. Over the course of its history, McKesson has grown by providing pharmaceutical and medical-surgical supply management across the spectrum of care; healthcare information technology for hospitals, physicians, homecare and payors; hospital and retail pharmacy automation; and services for manufacturers and payors designed to improve outcomes for patients. For more information, visit http://www.mckesson.com

    For additional information, please contact:
    Health Robotics S.r.l.
    Gaspar G. DeViedma
    Altmanstrasse 9A, Bozen, Sud-Tyrol, I-39100
    USA: +1-609-980-7976
    EUROPE: +39-346-963-4934
    gaspar.deviedma@health-robotics.com

    McKesson Corporation
    Clay Courville
    Vice President, Marketing
    +1-724-741-8111
    clay.courville@mckesson.com



'/>"/>
SOURCE Health Robotics
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. 14th Annual Wharton Health Care Business Conference to Feature CEOs from WebMD, McKesson, Humana and Given Imaging
2. BIO-key(R) Biometric Identification Solution Deployed by McKesson
3. PSKW Expands Its Lawsuit Against McKesson to Seek Assignment of McKessons Patent Application
4. Artromick Aligns with McKesson to Enhance Medication Safety at the Patients Bedside
5. iCardiac Expands Sales and Marketing Team
6. Zeus Expands International Support With New Hires
7. Digitas Health Expands Adding Two Key Locations
8. GenVec Expands Contract Supporting Malaria Vaccine Program
9. Biomodels Expands Efforts in Cancer Supportive Care, Pulmonary Fibrosis; Preclinical Research Organization Names Dr. Stephen T. Sonis as Partner
10. Signostics Closes Follow-On Financing of US$4 Million, Expands Board of Directors
11. Regado Biosciences Expands Medical Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... October 11, 2017 , ... At ... Purple announced Dr. Suneel I. Sheikh, the co-founder, CEO and chief research scientist ... has been selected for membership in ARCS Alumni Hall of Fame . ...
(Date:10/11/2017)... ... October 11, 2017 , ... ComplianceOnline’s Medical Device Summit is back for ... June 2018 in San Francisco, CA. The Summit brings together current and former FDA ... board directors and government officials from around the world to address key issues in ...
(Date:10/11/2017)... HILLS, Calif. , Oct. 11, 2017  SkylineDx today ... (ICR) and University of Leeds ... risk-stratify patients with multiple myeloma (MM), in a multi-centric Phase ... University of Leeds is the sponsor ... and ICR will perform the testing services to include high-risk ...
(Date:10/11/2017)... , ... October 11, 2017 , ... ... (FDA) has granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer ... treatment of osteosarcoma. SBT-100 is able to cross the cell membrane and bind ...
Breaking Biology Technology:
(Date:8/23/2017)... , Aug. 23, 2017  The general public,s help is being enlisted ... bacteria that live in and on the human body –and are believed ... The Microbiome Immunity ... human microbiome, starting with the gut. The project's goal is to help ... credit: IBM ...
(Date:6/30/2017)... 2017 Today, American Trucking Associations announced ... face and eye tracking software, became the newest ... "Artificial intelligence and advanced sensing ... a driver,s attentiveness levels while on the road.  ... detect fatigue and prevent potential accidents, which could ...
(Date:5/23/2017)... robotic gym for the rehabilitation and functional motor sense evaluation of lower ... . The first 30 robots will be available from June in ... The technology was developed and patented at the IIT laboratories and has ... to a 10 million euro investment from entrepreneur Sergio Dompè. ... ...
Breaking Biology News(10 mins):